A significant reduction in serum IL-1-beta levels was observed when comparing ME/CFS patients without immunodeficiencies to the healthy control group (Figure 3A). The gene discussed is IL1B; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.